Biotechnology healthtech company Mnemo Therapeutics, developing cell therapies using a target identification engine, has announced the completion of its €75 million ($90 million) Series A financing.
The Paris-based company has set the record with France's largest Series A round, taking the spot from Vade Secure that raised a €65 million round in 2019.
The country's largest Series A financing was...
